Clorox Director Matthew J. Shattock Acquires Deferred Stock Units for Board Fees
CLOROX CO /DE/
Subscribe to track CLX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š SEC Form 4: CLOROX CO /DE/ ($CLX)
š¤ Insider: Matthew J Shattock (Director)
š
Date: 2026-09-30
š¹ Type: Award / Grant (Deferred Stock Units)
š¹ Shares: 648.07 (Fee Deferral) + 255.38 (Dividend Reinvestment)
š¹ Price: $0.00
š¹ Total Holdings: 21,850.59 units
ā ļø Significance: Low (Routine Director Compensation)
Comprehensive Analysis
Insider Filing Analysis: Clorox Co ($CLX)
Overview
On October 2, 2026, Clorox Co director Matthew J. Shattock filed a Form 4 reporting acquisitions of Deferred Stock Units (DSUs) under the company's Independent Directors' Deferred Compensation Plan.
Key Transaction Details
- 2026-08-28: Acquired 255.3782 Deferred Stock Units via automatic dividend reinvestment.
- 2026-09-30: Acquired 648.0681 Deferred Stock Units in lieu of quarterly director cash retainers/fees.
- Price: $0.00 per unit (equity compensation / fee deferral).
- Settlement: 1-for-1 into Clorox common stock upon retirement or termination of board service.
- Ending Balance: 21,850.5936 Deferred Stock Units held directly.
Assessment
This filing represents standard, scheduled equity compensation for non-employee directors, including voluntary or plan-mandated deferral of quarterly director fees and dividend reinvestment. Because this is not an open-market purchase or sale, it carries Low trading significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.